Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc.

PBHยทNYSE

$45.44

-1.1%
HealthcareMedical - Distribution

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

At a Glance

Live Snapshot
Market Cap$2.15B
EPS3.9300
P/E Ratio11.56
Earnings Date08/06/2026
6.76%
Return on Invested Capital
-12%
3Y-1202.0%
5Y-7.0%
10Y+97.0%
10.08%
Return on Equity
-14%
3Y-277.0%
5Y-17.0%
10Y+20.0%
5.45%
Return on Assets
-14%
3Y-322.0%
5Y+13.0%
10Y+207.0%
Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. Management Team

PBH ยท NYSE
MC

Ms. Christine Sacco CPA

Chief Financial Officer & Chief Operating Officer

Compensation

$970,884

Born 1976(Age 50)
female
DS

Dean Siegal

Director of Communications

MP

Mr. Philip David Terpolilli C.F.A.

Director of Investor Relations

male
MA

Mr. Adel Mekhail

Executive Vice President of Marketing & Sales

Compensation

$861,557

Born 1961(Age 65)
male
MJ

Mr. Jeffrey Zerillo

Senior Vice President of Operations

Compensation

$531,270

Born 1961(Age 65)
male
MM

Ms. Mary Beth Fritz

Senior Vice President of Quality & Regulatory Affairs

female
MW

Mr. William C. P'Pool J.D.

Senior Vice President, General Counsel & Corporate Secretary

Compensation

$860,439

Born 1965(Age 61)
male
pbh

Prestige Consumer Healthcare Inc. Insider Positioning

PBH ยท NYSE

During the last 12 months, insiders have sold $424K worth of PBH shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

2.2K

120.44K

Net Activity

-120K

-$120K

3-6 Months

Bought

0

0.00

Sold

1.0K

65.93K

Net Activity

-66K

-$66K

6-9 Months

Bought

0

0.00

Sold

4.0K

238.05K

Net Activity

-238K

-$238K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
ZJ

Zerillo Jeffrey

Officer: Senior Vp Operations

4.2K sharesโ€ข7 transactions

$246K

2
BJE

Byom John E

Director

3.0K sharesโ€ข1 transactions

$178K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $424K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$120K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

2 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.

SEC Filings

PBH - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2025

N/A

June 27, 2025
August 05, 2025
2025
DEF 14A

DEF 14A 2024

N/A

July 05, 2024
August 06, 2024
2024
DEF 14A

DEF 14A 2023

N/A

June 29, 2023
August 01, 2023
2023
DEF 14A

DEF 14A 2022

N/A

June 28, 2022
August 02, 2022
2022
DEF 14A

DEF 14A 2021

N/A

June 29, 2021
August 03, 2021
2021
DEF 14A

DEF 14A 2020

N/A

June 29, 2020
August 04, 2020
2020
DEF 14A

DEF 14A 2019

N/A

June 28, 2019
July 30, 2019
2019
DEF 14A

DEF 14A 2018

N/A

June 29, 2018
July 31, 2018
2018
DEF 14A

DEF 14A 2017

N/A

June 30, 2017
August 01, 2017
2017
DEF 14A

DEF 14A 2016

N/A

June 30, 2016
August 02, 2016
2016
Showing 1 to 10 of 21 filings